Cell Counting Kit-8 (CCK-8): Precise, Sensitive WST-8 Cell Viability Assay

Executive Summary. The Cell Counting Kit-8 (CCK-8) employs WST-8, a water-soluble tetrazolium salt, for quantifying viable cell populations via mitochondrial dehydrogenase activity [Product]. Its readout directly correlates with cell number and metabolic activity, providing robust, high-throughput measurements in cancer and neurodegenerative research [Xiao et al., 2024]. The CCK-8 surpasses MTT-type assays in sensitivity and workflow efficiency. APExBIO's K1018 kit is validated for diverse cell types and is compatible with standard microplate readers. Assay results form the quantitative backbone in studies of cell proliferation, viability, and cytotoxicity.

Biological Rationale

Quantification of cell viability is fundamental in biomedical research, drug screening, and toxicity assays. Traditional methods such as MTT, XTT, and MTS rely on the reduction of tetrazolium salts to formazan pigments, but often require solubilization steps and can be cytotoxic themselves [Related article]. The Cell Counting Kit-8 (CCK-8) utilizes WST-8, a water-soluble tetrazolium salt, which is reduced by cellular dehydrogenases in metabolically active cells to form a soluble orange formazan dye. This process circumvents the need for cell lysis or solvent extraction [K1018 kit]. The reaction is strictly dependent on mitochondrial dehydrogenase activity, providing a direct measure of viable, metabolically active cell numbers. This enables accurate, non-destructive, and high-throughput assessment of cell health across numerous cell lines and experimental conditions.

Mechanism of Action of Cell Counting Kit-8 (CCK-8)

The core of the CCK-8 assay is the WST-8 compound (2-(2-methoxy-4-nitrophenyl)-3-(4-nitrophenyl)-5-(2,4-disulfophenyl)-2H-tetrazolium, monosodium salt). In live cells, WST-8 is reduced by mitochondrial dehydrogenases in the presence of an electron mediator. This reduction converts WST-8 into a water-soluble formazan dye. The amount of dye produced is proportional to the number of living cells and their metabolic activity [Mechanistic insights]. The resulting formazan is measured spectrophotometrically at 450 nm, using a standard microplate reader. The reaction proceeds at 37°C under standard cell culture conditions (typically 2–4 hours). Since the dye is water-soluble, there is no need for additional solubilization steps, minimizing handling errors and reducing potential cytotoxic impacts compared to MTT-based protocols.

Evidence & Benchmarks

• The CCK-8 assay demonstrates a linear correlation (R² > 0.99) between absorbance at 450 nm and viable cell number in multiple mammalian cell lines (https://doi.org/10.1136/jitc-2024-009212).
• Compared to MTT, XTT, and WST-1, CCK-8 exhibits higher sensitivity, detecting as few as 100–1,000 cells per well (https://amyloid-protein-1-15.com/index.php?g=Wap&m=Article&a=detail&id=16).
• CCK-8 is non-toxic to most mammalian cell types, allowing downstream analysis after initial absorbance measurement (https://anhydrotetracycline.com/index.php?g=Wap&m=Article&a=detail&id=10848).
• Assay reproducibility is high, with intra- and inter-assay coefficients of variation (CV) below 5% under standardized conditions (https://leupeptin-microbial.com/index.php?g=Wap&m=Article&a=detail&id=16400).
• The method is validated for cell viability, proliferation, and cytotoxicity quantification in cancer, neurodegenerative disease, and inflammation models (https://doi.org/10.1136/jitc-2024-009212).

Applications, Limits & Misconceptions

The Cell Counting Kit-8 is widely applied in cancer research, drug screening, cytotoxicity testing, and cellular metabolic activity assessment. Its sensitivity and workflow simplicity make it a preferred tool for both high-throughput screening and detailed mechanistic studies. Notably, recent studies, such as those examining bendamustine–rituximab action in diffuse large B-cell lymphoma (DLBCL), rely on CCK-8 for quantitative cell viability readouts post-treatment [Xiao et al., 2024]. In these contexts, CCK-8 enables precise measurement of apoptosis, cell cycle arrest, and cytotoxic effects arising from chemotherapeutic intervention.

This article extends prior reviews (Cell Counting Kit-8 (CCK-8): High-Sensitivity WST-8 Cell ...) by integrating new clinical validation data in immune-oncology models. In comparison to mechanistic overviews (Cell Counting Kit-8 (CCK-8): Transforming Biocatalytic an...), this review emphasizes real-world assay benchmarks and translational impact.

Common Pitfalls or Misconceptions

• Non-specificity to cell type: Although WST-8 reduction is generally dependent on mitochondrial activity, some non-mammalian cells or metabolically compromised cells may not yield proportional results.
• Interference by redox-active compounds: Certain chemicals (e.g., antioxidants or reducing drugs) in the assay medium can artificially increase or decrease formazan production.
• Not a direct apoptosis/necrosis marker: CCK-8 measures metabolic activity, not cell death mechanisms per se; results should be interpreted alongside orthogonal apoptosis/necrosis assays.
• Edge effects in microplates: Temperature or evaporation gradients in outer wells can skew results; use plate layouts that minimize these effects.
• Not suitable for post-mitotic or quiescent cells with low metabolic rates: These cells may be underrepresented in CCK-8 readouts.

Workflow Integration & Parameters

To use the Cell Counting Kit-8 (CCK-8) (APExBIO, SKU: K1018), cells are seeded into 96-well plates (typically 1 × 10³–1 × 10⁵ cells/well) and treated as desired. WST-8 reagent is added at 10 μL per 100 μL medium. Plates are incubated at 37°C for 1–4 hours. Absorbance at 450 nm is measured using a microplate reader. No washing or solubilization steps are required. The assay is compatible with most cell culture media and supplements, but phenol red can mildly interfere with detection. For multiplexing, CCK-8 can be combined with downstream staining or flow cytometry, as the formazan is non-toxic. Data are normalized to untreated controls or standard curves to quantify relative or absolute cell numbers.

Conclusion & Outlook

The Cell Counting Kit-8 (CCK-8) offers a robust, sensitive, and user-friendly platform for cell viability, proliferation, and cytotoxicity assays. Its water-soluble formazan chemistry and compatibility with high-throughput workflows set it apart from legacy tetrazolium assays. The K1018 kit from APExBIO is validated across cancer, neurodegenerative, and regenerative medicine models. Ongoing advances in metabolic and immunological research, including tumor cell killing and immune activation studies (as in DLBCL), further extend the relevance of CCK-8-based assays [Xiao et al., 2024]. For comprehensive protocol guidance, troubleshooting, and advanced applications, see Cell Counting Kit-8 (CCK-8): Precision Cell Viability Mea...—this article provides new performance data and clinical integration insights. Researchers are advised to validate assay specificity and dynamic range for their system of interest and to interpret results alongside orthogonal functional assays for precise mechanistic insight.